PAR 2.17% 23.5¢ paradigm biopharmaceuticals limited..

Ann: PAR Reports Successful Primary Endpoint in Phase 2 Trial, page-28

  1. 7,918 Posts.
    lightbulb Created with Sketch. 627
    In vet speak it is ‘the cat’s pyjamas’ of arthritis drugs
    LOL
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.